Telehealth Policy Debate: There is Greater Financial Value in Telehealth for Consumers than for Providers


  • William Baker (Moderator) New York University, Director, Global Debate Fund
  • Richard Heinzl WorldCare International, Inc., Global Medical Director
  • Richard Migliori UnitedHealth Group, Executive Vice President, Medical Affairs and Chief Medical Officer
  • David Gruber Alvarez & Marsal Healthcare Industry Group (HIG), Managing Director and Director of Research
  • Michael K. Gusmano The Hastings, Center Research Scholar




Session Summary:

The affirmative team provides a defense of the topic wording that can include parts or its entirety.  They will offer an initial “case” in their opening presentation, rebuild it in their response by refuting the negative attacks and offer key final comparisons in their rebuttals.  

The negative team’s job is to disprove the affirmative thesis. Their initial presentation should poke holes in the initial affirmative presentation and outline any of their own proofs for their side. The negative response will point out the key points unanswered by the affirmative response and refute attacks on their proofs. Their rebuttal will offer key final comparisons.  

The audience will vote for the most persuasive argument.


Download data is not yet available.

Author Biographies

William Baker (Moderator), New York University, Director, Global Debate Fund

Mr. Baker heads the NYU Global Debate Fund, housed in the Business & Society Dept of the Stern Business School and is the CIO for Baker Consulting Associates (BCA) based in Dallas, Texas.  As a leading authority on debate training, strategy & operations, Will is one of the top corporate debate consultants in NYC.  He is highly, sought after by for-profit and non-profit clients for executive coaching, curriculum development and speaking engagements. 

The Global Debate Fund was the first NYU program initiative to span their entire Global Network involving over 300 students, professors and alumni in conversations about issues of current controversy. BCA is one of the oldest African American management consulting firms in Dallas specializing in workforce development, time management, strategic planning and small business transitions onto social media platforms. 

He teaches argumentation in the Steinhardt School of Education and directs the award-winning NYU debate team.  In 2003, NYU captured the National Championships making Will the first African American director to secure that title since Melvin Tolson of Wiley College in 1935.   This season's topic focuses on National Health Insurance Reform Strategies. 
He has led national and local initiatives to make debate accessible to 200,000 students in low-income communities using diverse strategies to build youth expression including poetry, mediation, hip-hop, debate, reasoned discourse and town hall meetings. He has overseen the training of 5000 students, teachers and business professionals in the transformative power of debate.  

Mr. Baker is a Past President of the Committee of Religious NGOs at the UN and former UN Representative for the International Association for Religious Freedom to ECOSOC and UNICEF.   He also held elected office as a Queens Assembly District Leader.  

Richard Heinzl, WorldCare International, Inc., Global Medical Director

Richard Heinzl is a physician, humanitarian and entrepreneur whose current focus is technology and healthcare worldwide. He is Global Medical Director for WorldCare International, Inc. the Boston-based telemedicine company. In this role, Dr. Heinzl provides consultation and oversight on the creation and delivery of medical second opinions to WorldCare members, engages with clients worldwide, and contributes to the strategic direction of the organization.

Earlier in his career, Dr. Heinzl was the founder of Médecins Sans Frontières/Doctors Without Borders Canada (MSF Canada), which won the Nobel Peace Prize. He has been CEO and founder of several e-health companies.

Dr. Heinzl is a graduate of McMaster University’s DeGroote School of Medicine and completed postgraduate degrees related to global health at Harvard University and the University of Oxford. He is a Fellow of the American College of Preventive Medicine. He was awarded an Honorary Doctorate (LLD) from McMaster University and was named one of the “Hundred People Who Make a Difference” in Canada by Penguin Books. In 2016 he received the Alumni Award of Merit from the Harvard Chan School of Public Health. His Memoir, “Cambodia Calling” is published by Harper Collins.

Richard Migliori, UnitedHealth Group, Executive Vice President, Medical Affairs and Chief Medical Officer

In 2013, Dr. Richard Migliori was appointed executive vice president, Medical Affairs and chief medical officer for UnitedHealth Group, working with businesses across the enterprise to help improve health care quality, access and affordability. He is an active member of the company's Innovation Council, a group of key executives charged with the task of nurturing innovations in products and services and creating an environment that fosters new ideas and approaches to improving health and health care.

Previously, as executive vice president for Health Services, Dr. Migliori was responsible for the ongoing development, design, and adaptation of market leading clinical innovations aimed at ensuring clinical excellence, improving clinical and economic outcomes, and delivering robust business performance on behalf of UnitedHealth Group’s largest public and private sector clients.

Under his leadership at UnitedHealth Group, Dr. Migliori spearheaded the design, organization and management of national health care delivery networks. He has previously served on the Harvard University/Kennedy School of Government Health Care Delivery Policy Committee, and is a member of the American Society of Transplant Surgeons and the Advisory Committee on Transplantation advising the Secretary of Health and Human Services on public policy for human organ transplantation. He has published more than 35 articles on topics ranging from continuous quality improvement methods in a clinical setting to surgical oncology and solid organ transplant.

Dr. Migliori holds a Doctor of Medicine degree from Brown University and completed a National Health Research Fellowship in immunology, transplantation and oncology funded by the National Institutes of Health. He is certified by the American Board of Surgery.

David Gruber, Alvarez & Marsal Healthcare Industry Group (HIG), Managing Director and Director of Research

David Gruber, MBA is a Managing Director and Director of Research with Alvarez & Marsal Healthcare Industry Group (HIG) in New York, specializing in strategy, business development, consumer engagement, innovation, new ventures, technology, analytics and health benefits.

 He is currently responsible for thought leadership and model development within HIG, co-leads A&M health benefit activities and is involved in a wide range of consulting projects.
Dr. Gruber brings 30 years of diversified healthcare experience as a consultant, corporate executive, Wall Street analyst and physician.

Before A&M, he spent three years as the Founder of Healthcare Convergence Associates, a consulting firm focused on the convergence of healthcare, technology and the consumer. Assignments included working with a multinational to explore tele-health opportunities; a medical device maker to assess the feasibility of a proposed asthma and COPD technology; a pharmacy benefit manager to define innovative approaches to medication adherence in diabetes; a national retailer exploring health and wellness; a Canadian company interested in preventing nosocomial infections; and a major Wireless Health Institute to develop its strategic plan. He was also involved in three healthcare-related IT start-ups.

Until 2008, Dr. Gruber was VP of Corporate Development and New Ventures with the Johnson & Johnson Consumer Group of Companies, focusing on dermatology / aesthetics, consumer engagement and wireless health. In 1995-2004, he worked on Wall Street as a top-ten rated medical supplies and devices analyst at Lehman Brothers, Piper Jaffray and Sanford Bernstein. He was also the lead analyst for the initial public offering of Intuitive Surgical (robotics) and Given Imaging, and a merchant banking investment in Therasense.

Before entering Wall Street, Dr. Gruber was VP of Planning and Business Development for the $1.6 billion healthcare group at Bristol-Myers that included Zimmer, ConvaTec, Linvatec and Xomed-Treace. There, he represented the company on the Health Industry Manufacturing Association (HIMA) as it deliberated the merits of the Hillary Clinton healthcare reform proposals.

He recently appeared on NPR and C-Span; was quoted in the Washington Post, LA Times, The Deal, Healthcare Finance News, Managed Care Executive, Managed Care Outlook, Becker’s Hospital Review, Inside Health Policy; and published in the Journal of Diabetes Science & Technology, Turnaround Management Association Newsletter of Corporate Renewal and American Bankruptcy Institute Journal.

Dr. Gruber is a magna cum laude graduate of a six-year BS-MD program, having received a bachelor’s degree from Sophie Davis School of Biomedical Education, CCNY in 1981 and a medical degree from the Mt. Sinai School of Medicine in 1983. He also has an MBA from Columbia University and was a Kellogg Foundation National Fellow. He is currently a Senior Fellow, Healthcare Innovation and Technology Lab (HITLAB) at Columbia Presbyterian and an elected Trustee to the Teaneck Board of Education.

Michael K. Gusmano, The Hastings, Center Research Scholar

Michael Gusmano investigates health care equity in the U.S. and other countries. His research and publications have focused on health policy, aging, and comparative welfare state analysis. He is the codirector of the World Cities Project, the first effort to compare the performance of health, social, and long-term care systems in New York, London, Paris and Tokyo, the four largest cities among the wealthy nations of the world. In addition to being a research scholar at The Hastings Center, he is an associate professor of health policy at Rutgers University School of Public Health. He has authored four books and more than 100 scholarly articles. He is frequently interviewed by reporters about health policy issues.

Dr. Gusmano is an investigator on The Role of Values in Impact Assessment and Care Transitions in Aging Societies, a Singapore-based project that is producing an online casebook that focuses on ethical challenges of caring for people in an aging society. He is codirector of the Undocumented Patients project, concerned with finding ways to improve access to health care for undocumented immigrants. He serves on public policy initiatives related to his research, including the Bioethics Steering Committee of the White House Office of Science, Technology and Policy Initiative on Access to Health Care in Saharan Africa (2015-present) and the New York City Mayor’s Task Force on Immigration (2014-2015).

He holds a Ph.D. in political science from the University of Maryland at College Park and a master’s degree in public policy from the State University of New York at Albany. He was post-doctoral fellow in the Robert Wood Johnson Foundation Scholars in Health Policy program at Yale University.



How to Cite

Baker (Moderator), W., Heinzl, R., Migliori, R., Gruber, D., & Gusmano, M. K. (2018). Telehealth Policy Debate: There is Greater Financial Value in Telehealth for Consumers than for Providers. Telehealth and Medicine Today, 3. Retrieved from

Similar Articles

You may also start an advanced similarity search for this article.